Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $1.94 billion. The enterprise value is $1.84 billion.

Market Cap	1.94B
Enterprise Value	1.84B

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

DYN has 81.11 million shares outstanding. The number of shares has increased by 14.83% in one year.

Shares Outstanding	81.11M
Shares Change (YoY)	+14.83%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	87.98%
Float	52.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	21.20
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.30.

Current Ratio	2.53
Quick Ratio	n/a
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -136.40% and return on invested capital (ROIC) is -204.00%.

Return on Equity (ROE)	-136.40%
Return on Assets (ROA)	-103.70%
Return on Capital (ROIC)	-204.00%
Revenue Per Employee	n/a
Profits Per Employee	-$1.92M
Employee Count	123
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +143.06% in the last 52 weeks. The beta is 0.95, so DYN's price volatility has been similar to the market average.

Beta (1Y)	0.95
52-Week Price Change	+143.06%
50-Day Moving Average	25.85
200-Day Moving Average	15.16
Relative Strength Index (RSI)	38.38
Average Volume (30 Days)	1,420,930

Short Selling Information

The latest short interest is 8.08 million, so 9.96% of the outstanding shares have been sold short.

Short Interest	8.08M
Short Previous Month	6.82M
Short % of Shares Out	9.96%
Short % of Float	15.33%
Short Ratio (days to cover)	4.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-242.16M
Pretax Income	-235.94M
Net Income	-235.94M
EBITDA	-233.48M
EBIT	-235.94M
Earnings Per Share (EPS)	-$3.95

Full Income Statement

Balance Sheet

The company has $125.42 million in cash and $27.42 million in debt, giving a net cash position of $98.00 million or $1.21 per share.

Cash & Cash Equivalents	125.42M
Total Debt	27.42M
Net Cash	98.00M
Net Cash Per Share	$1.21
Equity / Book Value	91.29M
Book Value Per Share	1.13
Working Capital	78.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$188.16 million and capital expenditures -$729,000, giving a free cash flow of -$188.89 million.

Operating Cash Flow	-188.16M
Capital Expenditures	-729,000
Free Cash Flow	-188.89M
FCF Per Share	-$3.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.83%
Shareholder Yield	-14.83%
Earnings Yield	-12.19%
FCF Yield	-9.76%

Analyst Forecast

The average price target for DYN is $37.38, which is 56.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$37.38
Price Target Difference	56.66%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.68%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2